# Is Raven-Flint Building the Next U.S. Uranium Conversion Plant?

A startup has cleared two simultaneous regulatory and programmatic hurdles in a single announcement: Raven-Flint Nuclear Corp. confirmed on September 4 that the NRC has docketed its license application to expand uranium holdings at its Idaho Falls facility, while also confirming its selection as one of 12 companies in the second round of the DOE's Nuclear Energy Launch Pad program. The company has also demonstrated production of uranium hexafluoride (UF6) using a chemical process that eliminates elemental fluorine — the step it claims reduces capital cost, energy consumption, and chemical costs relative to conventional conversion. With a signed letter of intent with Aalo Atomics to take 100 percent of the planned pilot plant's output beginning in 2028, Raven-Flint has moved from bench chemistry to a credible, if still early-stage, commercial pathway. The U.S. currently has one operating commercial conversion facility: Solstice Advanced Material's Metropolis Works in Illinois, which projected output of 10,000 tons of UF6 in 2026. Raven-Flint's pilot plant is designed for 500 tons per year — one-twentieth of that scale — but the company's longer-term ambition is a commercial plant producing 5,000–10,000 tons annually, targeted for operation by 2030.

---

## The NRC Application: What Was Filed and What Happens Next

Raven-Flint's NRC docketing stems from a July application to raise the uranium possession limit at its Idaho Falls bench-scale research facility from its current administrative cap of 1.5 kg to up to 500 kg. The company proposed a maximum of 60 kg of UF6 on site under the application. This is not a production license — the company explicitly stated the Idaho Falls facility is for bench-scale process demonstration, not commercial production.

The NRC's pace is already visible: the agency issued a request for additional information on August 24, meaning the review clock is running and regulators are actively engaged. For a facility of this scale and purpose, NRC's information requests at this stage typically concern material control and accountancy, criticality safety, and chemical hazard analysis — all directly relevant given the UF6 chemistry involved.

Separately, Raven-Flint received a GAIN (Gateway for Accelerated Innovation in Nuclear) voucher in June, under which it will collaborate with Idaho National Laboratory to develop an integrated mass-balance, material control and accountancy, and stream characterization methodology for the pilot plant. That work is directly upstream of what any NRC license application for a commercial conversion facility will require.

---

## The Fluorine-Free Process: Technical Claim and What It Means

Conventional uranium conversion to UF6 uses elemental fluorine (F2), a highly reactive, corrosive gas that demands specialized materials, safety systems, and regulatory treatment. Raven-Flint's process is designed to achieve conversion without F2. CEO Nick Smith stated on LinkedIn that the approach offers 40–50 percent lower capital cost, 60–70 percent lower energy consumption, and 43 percent lower chemical costs compared to conventional methods.

These are the company's own figures from a LinkedIn post — not yet peer-reviewed or independently verified. That caveat matters. However, the fact that the company has now successfully produced UF6 at bench scale provides at least a proof-of-chemistry milestone. The economics will remain speculative until a pilot plant generates actual operating data.

If the process works at scale, the implications are meaningful. Fluorine handling is one of the primary barriers to entry for new conversion facilities — removing it from the equation could simplify [uranium enrichment](https://smrintel.com/glossary/enrichment) supply chain infrastructure and lower the threshold for siting new facilities. This is precisely why the DOE Launch Pad and GAIN programs are useful: they provide INL infrastructure and regulatory pathway support to de-risk demonstration before private capital is committed at pilot scale.

Smith's background adds credibility to the technical execution. He is a former INL employee who served as deputy director of the National Reactor Innovation Center and project director for the Molten Chloride Reactor Experiment. The cofounder's institutional knowledge of both INL operations and NRC process means the company is not learning the regulatory system from scratch.

---

## The Aalo Atomics Offtake: Commercial Signal, Not Commercial Certainty

Raven-Flint has signed a letter of intent with Aalo Atomics for conversion services beginning in 2028, with Aalo reportedly seeking to take 100 percent of the pilot plant's 500-ton annual output. Letters of intent are not binding purchase agreements, and Aalo itself is an early-stage reactor developer — so this is a startup-to-startup arrangement at this stage. Still, it demonstrates that at least one reactor developer is actively seeking alternative conversion supply rather than relying solely on Metropolis Works, and is willing to anchor a supplier's pilot program to do so.

For the broader nuclear fuel cycle, this kind of early offtake alignment is how [first-of-a-kind (FOAK)](https://smrintel.com/glossary/foak) infrastructure projects get built. The risk remains substantial: Raven-Flint must execute on NRC licensing, pilot plant construction, and process scale-up all within roughly two years to meet the 2028 target.

---

## Market Context: Three Conversion Entrants in One Year

Raven-Flint is not alone in targeting the U.S. conversion gap. [Uranium Energy Corp](https://smrintel.com/companies/uranium-energy-corp) received an NRC docket number for its planned conversion facility in March. FluxPoint unveiled its own conversion facility plans in April. The U.S. conversion market — currently dependent on a single facility — is attracting multiple entrants simultaneously, driven by SMR pipeline growth, HALEU demand projections, and the fuel security lessons of the past several years.

Whether the market can support multiple new entrants at commercial scale, or whether consolidation will occur before any of them reach full production, is an open question. What is clear is that Metropolis Works, projecting 10,000 tons in 2026, faces real competitive pressure for the first time in years — and that reactor developers are actively looking for supply alternatives.

---

## Key Takeaways

- Raven-Flint's NRC application was docketed following a July submission; the agency issued an information request on August 24, signaling active review.
- The company is one of 12 selected for round two of the DOE Nuclear Energy Launch Pad, providing INL access and regulatory support.
- Its fluorine-free UF6 conversion process has reached bench-scale demonstration; pilot plant capacity is targeted at 500 tons per year.
- Aalo Atomics has signed a letter of intent to take 100 percent of pilot output beginning in 2028.
- The company's long-term commercial target is 5,000–10,000 tons per year, with a facility targeted for 2030.
- The U.S. now has at least three companies — Raven-Flint, [Uranium Energy Corp](https://smrintel.com/companies/uranium-energy-corp), and FluxPoint — publicly pursuing new conversion capacity.
- Cost and safety claims from the proprietary process are self-reported and unverified at scale.

---

## Frequently Asked Questions

**What did Raven-Flint announce in September 2026?**
Raven-Flint announced that the NRC docketed its license application to expand uranium possession at its Idaho Falls facility, confirmed its selection for the DOE Nuclear Energy Launch Pad's second round, and disclosed that it has successfully produced UF6 at bench scale using its fluorine-free conversion process.

**What is Raven-Flint's uranium conversion process?**
The company has developed a chemical conversion method that produces UF6 without using elemental fluorine. The company claims this results in substantially lower capital, energy, and chemical costs compared to conventional conversion — though these figures come from company statements and have not been independently verified.

**How does Raven-Flint's planned capacity compare to the existing U.S. facility?**
Solstice Advanced Material's Metropolis Works projected 10,000 tons of UF6 production in 2026. Raven-Flint's pilot plant is designed for 500 tons per year. Its long-term commercial ambition is 5,000–10,000 tons annually by 2030.

**What is the Nuclear Energy Launch Pad?**
The Nuclear Energy Launch Pad is a DOE program administered through the National Reactor Innovation Center that provides selected companies with access to Idaho National Laboratory facilities, regulatory expertise, and support to accelerate the path from technology demonstration to commercial deployment. Raven-Flint was one of 12 companies selected in the program's second round in August.

**Who will buy Raven-Flint's conversion output?**
Aalo Atomics has signed a letter of intent to purchase 100 percent of the pilot plant's output beginning in 2028. This is a non-binding agreement between two early-stage companies and does not constitute a finalized commercial contract.

**Why does U.S. uranium conversion capacity matter for advanced reactors?**
Conversion of uranium ore concentrate to UF6 is the essential step before enrichment, whether to low-enriched uranium or [high-assay low-enriched uranium (HALEU)](https://smrintel.com/glossary/haleu). With SMR deployments accelerating and HALEU demand growing, reliance on a single domestic conversion facility creates a supply chain bottleneck. New entrants like Raven-Flint are attempting to address that concentration risk.